An Official Website of the United States Government
Company Information:
Name:
IMAGING BIOMETRICS, LLC
Address:
13416 Watertown Plank Road
Suite 260
ELM GROVE, WI 53122-
Suite 260
ELM GROVE, WI 53122-
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
Development of the Standard for Clinical Breast Perfusion Imaging
Award Year / Program / Phase:
2008 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Award Amount:
$107,000.00
Abstract:
DESCRIPTION (provided by applicant): Currently detection of breast tumors is most often accomplished with x-ray mammography. This is true despite the fact that mammography misses 5-15% of palpable breast cancers and has a positive predictive value of only
15-30%. Consequently, mammography requires… More
Product Development of a a Brain Tumor Perfusion Imaging Technology
Award Year / Program / Phase:
2008 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Award Amount:
$107,000.00
Abstract:
DESCRIPTION (provided by applicant): Primary brain tumors are the leading cause of cancer-related deaths in children and the fourth leading cause of cancer-related deaths in people under the age of 54. Recently, a significant increase in the incidence of b
rain tumors has been observed in people… More
Product Development of a Brain Tumor Perfusion Imaging Technology
Award Year / Program / Phase:
2010 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Todd R. Jensen
Award Amount:
$797,331.00
Abstract:
DESCRIPTION (provided by applicant): The goal of this Phase II SBIR proposal is to expand upon the research and development efforts, begun in Phase I, with new enhancements and product offerings, while also taking the initial steps to position the Company
for a multi-center clinical trial, planned… More
Automating MRI Delta T1 Methods for the Routine Assessment of Brain Tumor Burden
Award Year / Program / Phase:
2012 / STTR / Phase I
Agency:
HHS
Research Institution:
MEDICAL COLLEGE OF WISCONSIN
Abstract:
DESCRIPTION (provided by applicant): Contrast enhancement on MRI (magnetic resonance imaging) provides the best currently available approach for measuring tumor response to therapy in brain and other solid tumors. Accordingly, criteria have been formulated, by international committees, to guide the… More